XML 69 R59.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity Transactions (Details Narrative) - USD ($)
3 Months Ended
Feb. 02, 2021
Sep. 30, 2022
Sep. 30, 2021
Jun. 30, 2022
Common stock issued during period for acquisition value     $ 33,740  
Shares of common stock for consulting service, value     $ 175,000  
Common shares value   $ 16,713   $ 16,713
FinderFee [Member]        
Common stock issued during period for acquisition value   $ 33,740    
Common stock issued during period for acquisition   7,000 7,000  
Common shares value   $ 33,740    
VitaMedica [Member]        
Common stock issued during period for acquisition value     $ 100,000  
Common stock issued during period for acquisition     482,000  
Common Stock Shares [Member]        
Common stock issued during period for acquisition value   $ 6,000,000    
Common stock issued during period for acquisition   1,247,403    
Gross proceeds from sale of stocks $ 50,000      
Shares of common stock for consulting service, shares     35,000  
Shares of common stock for consulting service, value     $ 175,000  
Convertible Preferred Stock [Member]        
Sale of preferred stock shares 500,000      
Preferred stock convertible into shares of common stock ratio preferred stock is convertible into the Company’s common stock at a ratio of 1.8 shares of preferred stock for a single share      
Infusionz [Member] | Common Stocks [Member]        
Common stock issued during period for acquisition value     $ 1,764,876  
Common stock issued during period for acquisition     306,945